References:
  1. Park, M., Cook, A. R., Lim, J. T., Sun, Y., & Dickens, B. L. (2020). A systematic review of COVID-19 epidemiology based on current evidence. Journal of Clinical Medicine, 9(4), 967. https://doi.org/10.3390/jcm9040967
  2. Bulut, C. & Kato, Y. (2020). Epidemiology of COVID-19. Turkish Journal of Medical Sciences, 50(SI-1), 563-570. https://doi.org/10.1007/s10916-020-01586-7
  3. Lipsitch, M., Swerdlow, D. L., & Finelli, L. (2020). Defining the epidemiology of Covid-19 studies needed. New England Journal of Medicine, 382(13), 1194-1196. DOI: 10.1056/NEJMp2002125
  4. Dong, Y., Mo, X., Hu, Y., Qi, X., Jiang, F., Jiang, Z., & Tong, S. (2020). Epidemiology of COVID-19 among children in China. Pediatrics, 145(6), e20200702. DOI: https://doi.org/10.1542/peds.2020-0702
  5. McMichael, T. M., Currie, D. W., Clark, S., Pogosjans, S., Kay, M., Schwartz, N. G., … & Ferro, J. (2020). Epidemiology of Covid-19 in a long-term care facility in King County, Washington. New England Journal of Medicine, 382(21), 2005-2011. DOI: 10.1056/NEJMoa2005412
  6. Zhai, P., Ding, Y., Wu, X., Long, J., Zhong, Y., & Li, Y. (2020). The epidemiology, diagnosis and treatment of COVID-19. International Journal of Antimicrobial Agents, 55(5), 105955. https://doi.org/10.1016/j.ijantimicag.2020.105955
  7. Xie, J., Tong, Z., Guan, X., Du, B., Qiu, H., & Slutsky, A. S. (2020). Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Medicine, 46, 837–840. https://doi.org/10.1007/s00134-020-05979-7.
  8. Van Lancker, W., & Parolin, Z. (2020). COVID-19, school closures, and child poverty: a social crisis in the making. The Lancet Public Health, 5(5), 243-244. https://doi.org/10.1016/S2468-2667(20)30084-0
  9. Fernandes, N. (2020). Economic effects of coronavirus outbreak (COVID-19) on the world economy. Available at Social Science Research Network, http://dx.doi.org/10.2139/ssrn.3557504
  10. Klein, B. C., & Busis, N. A. (2020). COVID-19 is catalyzing the adoption of teleneurology N eurology, 94:903-904. https://doi.org/10.1212/WNL.0000000000009494
  11. Clay, J. M., & Parker, M. O. (2020). Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet Public Health, 5(5), 259. https://doi.org/10.3390/ijerph17134677
  12. Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet. Respiratory Medicine, 8(4), 21.https://  doi: 10.1016/S2213-2600(20)30116-8
  13. Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., & Chen, G. (2020). Characteristics of COVID-19 infection in Beijing. Journal of Infection, 80, 401-406. https://doi.org/10.1016/j.jinf.2020.02.018
  14. Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 24, 91-98. https://doi.org/10.1016/j.jare.2020.03.005
  15. Shi, Y., Wang, Y., Shao, C., Huang, J., Gan, J., Huang, X., & Melino, G. (2020). COVID-19 infection: The Perspectives on Immune Responses, 27 , pages1451–1454.https://doi.org/10.1038/s41418-020-0530-3
  16. 16)Bernheim, A., Mei, X., Huang, M., Yang, Y., Fayad, Z. A., Zhang, N., … & Li, S. (2020). Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology, 295, 685–691. https://doi.org/10.1148/radiol.2020200463
  17. Ng, M. Y., Lee, E. Y., Yang, J., Yang, F., Li, X., Wang, H., & Hui, C. K. M. (2020). Imaging profile of the COVID-19 infection: radiologic findings and literature review. Radiology: Cardiothoracic Imaging, 2(1), e200034. 10.1109/RBME.2020.2990959.
  18. Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., … & Chen, G. (2020). Characteristics of COVID-19 infection in Beijing. Journal of Infection, 80(4), 401-406. https://doi.org/10.1016/j.jinf.2020.02.018.
  19. Lei, S., Jiang, F., Su, W., Chen, C., Chen, J., Mei, W., … & Xia, Z. Y. (2020). Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine, 21, 100331. doi.org/10.1016/j.eclinm.2020.100331.
  20. Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R., … & Peng, P. (2020). Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of Oncology, 31(7), 894-901. https://doi.org/10.1016/j.annonc.2020.03.296.
  21. Hu, Z., Song, C., Xu, C., Jin, G., Chen, Y., Xu, X., … & Wang, J. (2020). Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China. Science China Life Sciences, 63(5), 706-711. https://doi.org/10.1007/s11427-020-1661-4.
  22. Mi, B., Chen, L., Xiong, Y., Xue, H., Zhou, W., & Liu, G. (2020). Characteristics and early prognosis of COVID-19 infection in fracture patients. The Journal of Bone and Joint Surgery. 102(9), 750-758. doi: 10.2106/JBJS.20.00390.
  23. Onder, G., Rezza, G., & Brusaferro, S. (2020). Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. The Journal of American Medical Association, 323(18), 1775-1776.
  24. Yang, W., Cao, Q., Qin, L., Wang, X., Cheng, Z., Pan, A., … & Yan, F. (2020). Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19): A multi-center study in Wenzhou city, Zhejiang, China. Journal of Infection, 80(4), 388-393. https://doi.org/10.1016/j.jinf.2020.02.016.
  25. Wu, Z., & McGoogan, J. M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. The Journal of American Medical Association, 323(13), 1239-1242.
  26. Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C. W., & Xia, Z. (2020). Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). Journal of General Internal Medicine, 35, 1545–1549. DOI: 10.1007/s11606-020-05762-w.
  27. Huang, X., Wei, F., Hu, L., Wen, L., & Chen, K. (2020). Epidemiology and clinical characteristics of COVID-19. Archives of Iranian Medicine, 23(4), 268-271.doi:  10.34172/aim.2020.09.
  28. Jin, X., Lian, J. S., Hu, J. H., Gao, J., Zheng, L., Zhang, Y. M., … & Yu, G. D. (2020). Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut, 69(6), 1002-1009. http://dx.doi.org/10.1136/gutjnl-2020-320926.
  29. Mo, P., Xing, Y., Xiao, Y., Deng, L., Zhao, Q., Wang, H., … & Luo, M. (2020). Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa270.
  30. Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., … & Cao, H. (2020). Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clinical Infectous Diseases, 10. https://doi.org/10.1093/cid/ciaa199.
  31. Hong, H., Wang, Y., Chung, H. T., & Chen, C. J. (2020). Clinical characteristics of novel coronavirus disease 2019 (COVID-19) in newborns, infants and children. Pediatrics and Neonatology, 61(2), 131-132. https://doi.org/10.1016/j.pedneo.2020.03.001.
  32. Xiong, Y., Liu, Y., Cao, L., Wang, D., Guo, M., Jiang, A., … & Wu, H. (2020). Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients. Emerging Microbes and Infections, 9(1), 761-770. https://doi.org/10.1080/22221751.2020.1747363
  33. Shekerdemian, L. S., Mahmood, N. R., Wolfe, K. K., Riggs, B. J., Ross, C. E., McKiernan, C. A., & Priestley, M. A. (2020). Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatrics.  DOI: https:// 10.1001/jamapediatrics.2020.1948
  34. Qiao, J. (2020). What are the risks of COVID-19 infection in pregnant women?. The Lancet, 395(10226), 760-762. DOI:https://doi.org/10.1016/S0140-6736(20)30365-2.
  35. Henry, B. M., & Lippi, G. (2020). Chronic kidney disease is associated with severe corona virus disease 2019 (COVID-19) infection. International Urology and Nephrology, 52, 1193–1194 https://doi.org/10.1007/s11255-020-02451-9.
  36. Li, L. Q., Huang, T., Wang, Y. Q., Wang, Z. P., Liang, Y., Huang, T. B., & Wang, Y. (2020). COVID‐19 patients’ clinical characteristics, discharge rate, and fatality rate of meta‐analysis. Journal of Medical Virology, 92(6), 577-583. https://doi.org/10.1002/jmv.25757.
  37. Fang, L., Karakiulakis, G., & Roth, M. (2020). Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet. Respiratory Medicine, 8(4), e21. doi: 10.1016/S2213-2600(20)30116-8.
  38. Chen, L., Li, Q., Zheng, D., Jiang, H., Wei, Y., Zou, L., … & Zhao, Y. (2020). Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. New England Journal of Medicine. 382, 100. DOI: 10.1056/NEJMc2009226.
  39. Surveillances, V. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) China, 2020. China CDC Weekly, 2(8), 113-122.
  40. Filatov, A., Sharma, P., Hindi, F., & Espinosa, P. S. (2020). Neurological complications of coronavirus disease (COVID-19): Encephalopathy. Cureus, 12(3), e7352. doi: 10.7759/cureus.7352.
  41. Zu, Z. Y., Jiang, M. D., Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020). Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology, 200490. https://doi.org/10.1148/radiol.2020200490.
  42. Sun, P., Lu, X., Xu, C., Sun, W., & Pan, B. (2020). Understanding of COVID‐19 based on current evidence. Journal of medical virology, 92(6), 548-551. https://doi.org/10.1002/jmv.25722.
  43. Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends. 14(1), 72-73. https://doi.org/10.5582/bst.2020.01047
  44. Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19). In Statpearls [internet]. StatPearls Publishing.
  45. Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., … & Wei, J. (2020). Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. The Journal of American Medical Association, 323(16), 1582-1589.
  46. Dong, L., Hu, S., & Gao, J. (2020). Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discoveries & Therapeutics, 14(1), 58-60. https://doi.org/10.5582/ddt.2020.01012
  47. Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020). Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. The Journal of American Medical Association, 323(18), 1824-1836.
  48. Luo, P., Liu, Y., Qiu, L., Liu, X., Liu, D., & Li, J. (2020). Tocilizumab treatment in COVID‐19: A single center experience. Journal of Medical Virology, 92(7), 814-818. https://doi.org/10.1002/jmv.25801
  49. Ren, J. L., Zhang, A. H., & Wang, X. J. (2020). Traditional Chinese medicine for COVID-19 treatment. Pharmacological Research, 155, 104743.  doi: 10.1016/j.phrs.2020.104743.
  50. Wan, S., Xiang, Y., Fang, W., Zheng, Y., Li, B., Hu, Y., … & Huang, X. (2020). Clinical features and treatment of COVID‐19 patients in northeast Chongqing. Journal of Medical Virology. 92, 797-806.  https://doi.org/10.1002/jmv.25783
  51. Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., … & Schwartz, A. (2020). COVID-19 and cardiovascular disease. Circulation, 141(20), 1648-1655. https://doi.org/10.1161/CIRCULATIONAHA.120.046941.
  52. Lim, J., Jeon, S., Shin, H. Y., Kim, M. J., Seong, Y. M., Lee, W. J., … & Park, S. J. (2020). Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR. Journal of Korean Medical Science, 35(6), 79. https://doi.org/10.3346/jkms.2020.35.e79.
  53. Cai, Q., Yang, M., Liu, D., Chen, J., Shu, D., Xia, J., … & Shen, C. (2020). Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering. https://doi.org/10.1016/j.eng.2020.03.007.
  54. c, S. H., Lee, K. H., Kim, J. Y., Lee, Y. K., Ko, H., Kim, K. H., … & Kim, Y. H. (2020). Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean journal of radiology, 21(4), 494-500. https://doi.org/10.3348/kjr.2020.0132
  55. Kupferschmidt, K., & Cohen, J. (2020). Race to find COVID-19 treatments accelerates. American Association for the advancement of Science. 367(6485), 1412-1413. DOI: 10.1126/science.367.6485.1412.
  56. Cunningham, A. C., Goh, H. P., & Koh, D. (2020). Treatment of COVID-19: old tricks for new challenges. Critical Care. 24, 91.
  57. Ye, Q., Wang, B., & Mao, J. (2020). The pathogenesis and treatment of theCytokine Storm’in COVID-19. Journal of Infection, 80(6), 607-613. DOI:https://doi.org/10.1016/j.jinf.2020.03.037
  58. Bloch, E. M., Shoham, S., Casadevall, A., Sachais, B. S., Shaz, B., Winters, J. L., … & Pekosz, A. (2020). Deployment of convalescent plasma for the prevention and treatment of COVID-19. The Journal of Clinical Investigation, 130(6), 2757-2765. https://doi.org/10.1172/JCI138745.
  59. Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., … & Zhao, S. (2020). Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. Journal of the American College of Cardiology, 76(1), 122-124. doi: 10.1016/j.jacc.2020.05.001.
  60. Mehra, M. R., Desai, S. S., Ruschitzka, F., & Patel, A. N. (2020). Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet. https://doi.org/10.1016/S0140-6736(20)31180-6.
  61. Touret, F., & de Lamballerie, X. (2020). Of chloroquine and COVID-19. Antiviral Research, 177, 104762. https://doi.org/10.1016/j.antiviral.2020.104762
  62. Guastalegname, M., & Vallone, A. (2020). Could chloroquine/hydroxychloroquine be harmful in coronavirus disease 2019 (COVID-19) treatment?. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaa321.
  63. Colson, P., Rolain, J. M., Lagier, J. C., Brouqui, P., & Raoult, D. (2020). Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int Journal of Antimicrobial Agents, 105932(10.1016).
  64. Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433.
  65. Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., … & Nicastri, E. (2020). Compassionate use of remdesivir for patients with severe Covid-19. New England Journal of Medicine, 382(24), 2327-2336. DOI: 10.1056/NEJMoa2007016.
  66. Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., … & Lopez de Castilla, D. (2020). Remdesivir for the treatment of Covid-19—preliminary report. New England Journal of Medicine. DOI: 10.1056/NEJMoa2007764.
  67. Moore, J. B., & June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science, 368(6490), 473-474. DOI: 10.1126/science.abb8925.
  68. Rosa, S. G. V., & Santos, W. C. (2020). Clinical trials on drug repositioning for COVID-19 treatment. Pan American Journal of Public Health, 44, e40. https://doi.org/10.26633/RPSP.2020.40.
  69. Lu, Q., & Shi, Y. (2020). Coronavirus disease (COVID‐19) and neonate: What neonatologist needs to know? Journal of Medical Virology, 92(6), 564-567.  https://doi.org/10.1002/jmv.25740.
  70. Yang, H., Wang, C., & Poon, L. C. (2020). Novel coronavirus infection and pregnancy. Ultrasound in Obstetrics and Gynecology, 55(4), 435-437. doi: 10.1002/uog.22006.
  71. Mizumoto, K., Kagaya, K., & Chowell, G. (2020). Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China, January-February, 2020. medRxiv.doi:  https://doi.org/10.1101/2020.02.12.20022434.
  72. Shim, E., Tariq, A., Choi, W., Lee, Y., & Chowell, G. (2020). Transmission potential and severity of COVID-19 in South Korea. International Journal of Infectious Diseases. 93, 339-344. https://doi.org/10.1016/j.ijid.2020.03.031.
  73. Kucharski, A. J., Russell, T. W., Diamond, C., Liu, Y., Edmunds, J., Funk, S., … & Davies, N. (2020). Early dynamics of transmission and control of COVID-19: a mathematical modelling study. The lancet Infectious Diseases. 20(5), 553-558. https://doi.org/10.1016/S1473-3099(20)30144-4.
  74. Ludvigsson, J. F. (2020). Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adults. Acta Paediatrica, 109(6), 1088-1095.   https://doi.org/10.1111/apa.15270
  75. Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., … & Hoffman, K. L. (2020). Clinical characteristics of Covid-19 in New York city. New England Journal of Medicine. 382, 2372-2374. DOI: 10.1056/NEJMc2010419.
  76. Jiang, F., Deng, L., Zhang, L., Cai, Y., Cheung, C. W., & Xia, Z. (2020). Review of the clinical characteristics of coronavirus disease 2019 (COVID-19). Journal of General Internal Medicine, 35 , 1545–1549. doi: 10.3748/wjg.v26.i22.2987
  77. Zhang, L., Zhu, F., Xie, L., Wang, C., Wang, J., Chen, R., & Peng, P. (2020). Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Annals of Oncology, 31, 894-901. https://doi.org/10.1016/j.annonc.2020.03.296
  78. Wu, J., Liu, J., Zhao, X., Liu, C., Wang, W., Wang, D., & Cao, H. (2020). Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study. Clin Infect Dis, 10.
  79. Tang, B., Wang, X., Li, Q., Bragazzi, N. L., Tang, S., Xiao, Y., & Wu, J. (2020). Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. Journal of Clinical Medicine, 9(2), 462. https://doi.org/10.1016/j.idm.2020.02.001
  80. Pan, L., Mu, M., Yang, P., Sun, Y., Wang, R., Yan, J., & Jin, Y. (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. The American Journal of Gastroenterology, 26(14): 1546–1553.  doi: 10.3748/wjg.v26.i14.1546
  81. Han, C., Duan, C., Zhang, S., Spiegel, B., Shi, H., Wang, W., & Hou, X. (2020). Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes. The American Journal of Gastroenterology. 115, 916-923. doi: 10.14309/ajg.0000000000000664.
  82. Soetikno, R., Teoh, A. Y., Kaltenbach, T., Lau, J. Y., Asokkumar, R., Cabral-Prodigalidad, P., & Shergill, A. (2020). Considerations in performing endoscopy during the COVID-19 pandemic. Gastrointestinal Endoscopy. 92(1): 176–183.  doi: 10.1016/j.gie.2020.03.3758.
  83. Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., Manson, J. J., & HLH Across Speciality Collaboration. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet (London, England), 395(10229), 1033-1034.  doi: 10.1016/S0140-6736(20)30628-0.
  84. Hollander, J. E., & Carr, B. G. (2020). Virtually perfect? Telemedicine for COVID-19. New England Journal of Medicine, 382(18), 1679-1681. DOI: 10.1056/NEJMp2003539.
  85. Zheng, Y. Y., Ma, Y. T., Zhang, J. Y., & Xie, X. (2020). COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5), 259-260. https://doi.org/10.1038/s41569-020-0360-5.
  86. Akalin, E., Azzi, Y., Bartash, R., Seethamraju, H., Parides, M., Hemmige, V., … & Liriano-Ward, L. (2020). Covid-19 and kidney transplantation. New England Journal of Medicine. 382:2475-2477. DOI: 10.1056/NEJMc2011117.
  87. Velavan, T. P., & Meyer, C. G. (2020). The COVID‐19 epidemic. Tropical Medicine & International Health, 25(3), 278-280. doi: 10.1111/tmi.13383.
  88. Le, T. T., Andreadakis, Z., Kumar, A., Roman, R. G., Tollefsen, S., Saville, M., & Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(5), 305-306. https://doi.org/10.1038/d41573-020-00073-5.
  89. Cao, X. (2020). COVID-19: immunopathology and its implications for therapy. Nature Reviews Immunology, 20(5), 269-270. DOIhttps://doi.org/10.1038/s41577-020-0308-3.
  90. Poyiadji, N., Shahin, G., Noujaim, D., Stone, M., Patel, S., & Griffith, B. (2020). COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology, 201187. https://doi.org/10.1148/radiol.2020201187.
  91. Remuzzi, A., & Remuzzi, G. (2020). COVID-19 and Italy: what next?. The Lancet. 395(10231), 1225-1228. https://doi.org/10.1016/S0140-6736(20)30627-9.
  92. Xia, Y., Jin, R., Zhao, J., Li, W., & Shen, H. (2020). Risk of COVID-19 for cancer patients. Lancet Oncol, 21(4), 180. https://doi.org/10.1016/ S1470-2045(20)30150-9.
  93. Nishiura, H., Oshitani, H., Kobayashi, T., Saito, T., Sunagawa, T., Matsui, T., … & Suzuki, M. (2020). Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19). medRxiv.doi:  https://doi.org/10.1101/2020.02.28.20029272.
  94. Tian, S., Hu, N., Lou, J., Chen, K., Kang, X., Xiang, Z., … & Chen, G. (2020). Characteristics of COVID-19 infection in Beijing. Journal of Infection. 80(4), 401-406. https://doi.org/10.1016/j.jinf.2020.02.018
  95. Yancy, C. W. (2020). COVID-19 and African Americans. Jama.
  96. Lee, P. I., Hu, Y. L., Chen, P. Y., Huang, Y. C., & Hsueh, P. R. (2020). Are children less susceptible to COVID-19?. Journal of Microbiology, Immunology, and Infection. 53(3): 371–372.  doi: 10.1016/j.jmii.2020.02.011.
  97. Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020). Developing Covid-19 vaccines at pandemic speed. New England Journal of Medicine, 382(21), 1969-1973. DOI: 10.1056/NEJMp2005630.
  98. Rothan, H. A., & Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433.
  99. Pfefferbaum, B., & North, C. S. (2020). Mental health and the Covid-19 pandemic. New England Journal of Medicine. DOI: 10.1056/NEJMp2008017.